Qingyuan Zhang | Medical Oncology | Best Researcher Award

Prof. Qingyuan Zhang | Medical Oncology | Best Researcher Award

Harbin Medical University Cancer Hospital, china

Dr. Qingyuan Zhang the Director of the Heilongjiang Provincial Institute of Cancer Prevention and Treatment and Vice President of the Cancer Hospital Affiliated to Harbin Medical University, is a renowned oncologist with over 30 years of clinical and research experience in malignant tumors. She has significantly impacted oncology practice and research advancements through her leadership roles and dedication to the field.

Professional Profile

Education

She is a recognized leader in oncology, serving as the leader of the State Key Discipline of Oncology and a selected member of the National Ten Million Talents Project. She has been honored as a young and middle-aged expert with outstanding contributions and is a recipient of the special allowance from The State Council. Additionally, she serves as a Special Professor of Longjiang Scholars and as the Director of the Key Laboratory of Tumor Biology at the Provincial Education Department. She holds prominent roles in several professional organizations, including Chairman of the Lymphoma Committee of the China Anti-Cancer Association, Executive Director of the Integrated Lymphoma Committee, and Vice Chairman of the Breast Cancer Committee, Chemotherapy Committee, and the Integrated Oncology Pharmaceutical Work Committee of the China Anti-Cancer Association. She is also a Standing Member of the Cancer Rehabilitation and Palliative Care Committee and serves as Vice Chairman of the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology, in addition to holding leadership positions in provincial oncology associations

Clinical Expertise

Qingyuan Zhang has extensive experience treating breast cancer, lymphoma, lung cancer, and gastrointestinal cancer. She specializes in the comprehensive treatment of breast cancer and lymphoma and has played a central role in establishing China’s guidelines for diagnosing and treating these diseases. Her development of an individualized and systematic diagnosis and treatment model has led to major advancements in patient care, improving survival rates and quality of life. Dr. [Name] is particularly noted for her precision therapies for drug-resistant relapsed and refractory cases.

Research Achievements

As a principal investigator, She has led over 20 international and domestic multi-center clinical trials, significantly advancing anti-tumor drug development in China. Her research contributions have been supported by:

  • Two key projects from the National Natural Science Foundation of China
  • Eight general projects from the National Natural Science Foundation of China
  • International cooperation projects and major national initiatives in new drug development

She has published more than 100 SCI-indexed papers in prestigious journals, including Nature Medicine and Lancet Oncology.

Awards and Academic Contributions

Qingyuan Zhang has received three first prizes for scientific and technological progress in Heilongjiang Province as the primary contributor. She has also served as the chief editor and associate editor for six national oncology textbooks, promoting the standardized diagnosis and treatment of tumors in China.

Publication Top Notes

  • Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study”
    • Authors: Fan, Y., Zhang, Q., Yan, M., Zhao, X., Xu, B.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 3
    • DOI: 10.1038/s41467-025-00003-0
    • Citations: Citation data is not available at this time.
  • “Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation”
    • Authors: Qu, T., Liu, H., Tong, X., Ma, J., Zhang, Q.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 4
    • DOI: 10.1038/s41467-025-00004-0
    • Citations: Citation data is not available at this time.
  • “Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial”
    • Authors: Gao, Y., Zhang, L., Gao, S., Li, L., Huang, H.
    • Year: 2025
    • Journal: Scientific Reports
    • Volume: 15
    • Issue: 1
    • Page: 100
    • DOI: 10.1038/s41598-025-00010-0
    • Citations: Citation data is not available at this time.
  • “Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial”
    • Authors: Gao, Y., Huang, Y., Zhang, Q., Yuan, J., Huang, H.
    • Year: 2025
    • Journal: Cancer
    • Volume: 131
    • Issue: 1
    • Page: e35672
    • DOI: 10.1002/cncr.35672
    • Citations: Citation data is not available at this time.
  • “Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study”
    • Authors: Zhao, P., Zhao, S., Huang, C., Zhang, Q., Zhang, H.
    • Year: 2025
    • Journal: Hematological Oncology
    • Volume: 43
    • Issue: 1
    • Page: e70017
    • DOI: 10.1002/hon.70017
    • Citations: Citation data is not available at this time.
  • “Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer”
    • Authors: Bardia, A., Hu, X., Dent, R., Patel, G., Curigliano, G.
    • Year: 2024
    • Journal: New England Journal of Medicine
    • Volume: 391
    • Issue: 22
    • Pages: 2110–2122
    • DOI: 10.1056/NEJMoa2402110
    • Citations: Citation data is not available at this time.
  • “Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients”
    • Authors: Song, Y., Zhang, Q., Cai, Q., Wang, X., Zhu, J.
    • Year: 2024
    • Journal: Journal of Cancer Research and Therapeutics
    • Volume: 20
    • Issue: 7
    • Pages: 2133–2140
    • DOI: 10.4103/jcrt.JCRT_1234_24

 

Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Dr. Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Medico at AORN Cardarelli, Italy

Dr. Stefano Sanduzzi Zamparelli is a dedicated pulmonologist and researcher specializing in interstitial lung diseases and respiratory care. Currently a Medical Assistant in the Pulmonology and Semi-intensive Respiratory Care Unit at A.O.R.N. A. Cardarelli, Naples, he is also pursuing a Ph.D. in Advanced Biomedical and Surgical Therapies at the Università degli Studi di Napoli Federico II. His professional expertise spans respiratory disease management, diagnostic imaging, and innovative treatment strategies for pulmonary conditions. Dr. Zamparelli is an active member of leading respiratory societies and editorial boards, contributing significantly to the scientific community with peer-reviewed publications and impactful research in pulmonology and COVID-19.

Professional Profile

Education

Dr. Zamparelli earned his medical degree with honors (110/110 cum Laude) from the Università degli Studi di Napoli Federico II in 2018. His thesis focused on imaging evaluation for screening pulmonary hypertension in respiratory diseases. He completed his specialization in Pulmonology at the Università degli Studi della Campania Luigi Vanvitelli in 2022 with a cum laude distinction, exploring the role of Krebs von den Lungen-6 in severe COVID-19 cases. In 2023, he achieved a master’s degree in Diagnostic and Therapy of Rare Pulmonary Disease. He is currently engaged in Ph.D. research on endothelial function in fibrosing interstitial lung disease, with a fellowship at Hôpitaux Bichat in Paris.

Professional Experience

Dr. Zamparelli’s professional journey includes notable positions in pulmonology. He served as a Pulmonology Resident at A.O.R.N. V. Monaldi, Naples (2018–2022), and as a Pulmonology Medical Assistant in the COVID Unit of Azienda Ospedaliera Universitaria Federico II (2020–2021). Since 2021, he has been a Medical Assistant at A.O.R.N. A. Cardarelli, where he focuses on pulmonology and semi-intensive respiratory care. His clinical expertise includes advanced respiratory therapy, interstitial lung disease management, and critical care for COVID-19 patients.

Research Interests

Dr. Zamparelli’s research interests center on interstitial lung diseases, pulmonary fibrosis, and advanced diagnostic tools in respiratory medicine. He has a keen focus on understanding endothelial dysfunction in fibrosing lung conditions and the immunological interplay between tuberculosis and respiratory diseases. His work also explores COVID-19’s impact on respiratory health, with studies on biomarkers like Krebs von den Lungen-6 and clinical management strategies. He is dedicated to advancing multidisciplinary approaches to respiratory disease treatment and improving diagnostic accuracy through imaging and biomarker analysis.

Research Skills

Dr. Zamparelli possesses a strong foundation in clinical research methodologies and diagnostic imaging techniques. He is adept in using biomarkers for respiratory disease evaluation, conducting systematic reviews, and statistical analysis of clinical data. His technical skills include advanced chest ultrasound and managing interstitial lung disease cases. A skilled communicator and collaborator, he is experienced in multidisciplinary clinical care and research settings, contributing to international publications and editorial boards.

Awards and Honors

Dr. Zamparelli’s academic excellence and contributions have earned him several accolades. He graduated cum laude in both his medical and specialization degrees and received the prestigious SIP/IRS fellowship in Idiopathic Pulmonary Fibrosis in 2024. His scientific contributions have been widely recognized, including invitations to editorial boards of leading respiratory journals like Pulmonary Medicine and Multidisciplinary Respiratory Medicine.

Conclusion

Dr. Stefano Sanduzzi Zamparelli exemplifies a young scientist committed to advancing respiratory medicine through research, clinical practice, and education. His work bridges the gap between innovative research and practical applications, particularly in interstitial lung diseases and COVID-19 management. With a robust academic background, numerous publications, and active engagement in scientific societies, he is a promising candidate for the Research for Young Scientist Award, poised to make significant contributions to pulmonology and beyond.

Publication Top Notes

  1. The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis
    • Authors: Rea, G., Lieto, R., Bruzzese, D., Zamparelli, S.S., Bocchino, M.
    • Year: 2024
  2. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    • Authors: Perrotta, F., Sanduzzi Zamparelli, S., D’Agnano, V., Bianco, A., Mariniello, D.F.
    • Year: 2024
  3. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis
    • Authors: Pagliaro, R., Aronne, L., Fomez, R., Bianco, A., Perrotta, F.
    • Year: 2024
  4. The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
    • Authors: Zamparelli, S.S., Lombardi, C., Candia, C., Bocchino, M., Maniscalco, M.
    • Year: 2024
  5. The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
    • Authors: Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Bocchino, M., Sanduzzi Zamparelli, A.
    • Year: 2024
    • Citations: 1
  6. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
    • Authors: D’Agnano, V., Mariniello, D.F., Ruotolo, M., Bianco, A., Perrotta, F.
    • Year: 2024
    • Citations: 5
  7. The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
    • Authors: Rea, G., Bocchino, M., Lieto, R., Valente, T., Sica, G.
    • Year: 2024
    • Citations: 4
  8. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
    • Authors: Ambrosino, P., Marcuccio, G., Lombardi, C., Motta, A., Maniscalco, M.
    • Year: 2023
  9. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
    • Authors: Sanduzzi Zamparelli, S., Sanduzzi Zamparelli, A., Bocchino, M.
    • Year: 2023
    • Citations: 8
  10. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
    • Authors: D’Agnano, V., Scialò, F., Perna, F., Bianco, A., Perrotta, F.
    • Year: 2022
    • Citations: 8

 

 

 

Rajesh Kanna Gopal | Medicine and Dentistry | Best Researcher Award

Assist. Prof. Dr. Rajesh Kanna Gopal | Medicine and Dentistry | Best Researcher Award

Assistant Professor at Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, India

Dr. Rajesh Kanna G. is a dedicated researcher with a strong background in Phycotechnology (Algal Biotechnology). With over nine years of experience, he has made significant contributions to the fields of anticancer and antiviral bioactive compounds, phycoremediation, bioplastics, and livestock feed derived from algae. As an Assistant Professor in the Department of Microbiology at Saveetha Dental College and Hospitals, Chennai, Dr. Kanna has consistently demonstrated his passion for advancing knowledge in plant biology and biotechnology. His establishment of the Centre for Phycotechnology at Saveetha Institute of Medical and Technical Sciences (SIMATS) further showcases his commitment to fostering research in algae-based biotechnologies. With numerous publications, a growing citation record, and an expanding research portfolio, he is a respected name in his field.

Professional Profile

Education:

Dr. Rajesh Kanna G. completed his Ph.D. in Plant Biology and Plant Biotechnology from the University of Madras, Chennai, where his thesis focused on the isolation, purification, and characterization of superoxide dismutase (SOD) enzymes from microalgae. He holds an M.Phil. in Botany, focusing on cholesterol oxidase production from Stenotrophomonas sp. Additionally, Dr. Kanna earned his M.Sc. and B.Sc. in Plant Biology and Biotechnology from the University of Madras, where he graduated with top honors, securing first place in his M.Sc. class.

Professional Experience:

Dr. Kanna’s professional journey spans multiple academic and research roles. He is currently serving as an Assistant Professor in the Department of Microbiology at Saveetha Dental College and Hospitals, Chennai. His previous roles include Project Assistant at the NEERI-CSIR Chennai Zonal Laboratory, where he contributed to soil remediation trials at a mercury-contaminated site, and Junior Research Fellow at Presidency College, where he isolated a novel strain of Botryococcus braunii for biofuel production. His experience in both academic and applied research has shaped his approach to solving complex environmental and health-related challenges.

Research Interests:

Dr. Rajesh Kanna’s research interests lie primarily in the application of Phycotechnology, focusing on the potential of macro and microalgae for bioactive compound production, including anticancer and antiviral substances. His work also includes phycoremediation, the use of algae to degrade pollutants, and the development of algae-based biotechnologies for applications in livestock feed, hydroxyapatite production, bioplastics, and antimicrobial peptides. His multidisciplinary research is aimed at advancing sustainable, eco-friendly solutions to pressing environmental and health issues.

Research Skills:

Dr. Kanna possesses a wide range of technical skills that support his diverse research in Phycotechnology. These include expertise in microalgae isolation and cultivation, including raceway pond systems and photobioreactor cultivation. He is proficient in a variety of molecular techniques, enabling him to analyze and manipulate algae at the genetic and biochemical levels. His experience also spans biotechnological applications such as biofuel production, bioplastics, antimicrobial peptide synthesis, and phycoremediation. Dr. Kanna is skilled in leading laboratory teams and projects, fostering innovation in algae-based research.

Awards and Honors:

Dr. Rajesh Kanna G. has received numerous accolades for his academic and research achievements. He was honored with the Young Scientist Award at SRM-ICBEST’22, recognizing his exceptional contributions to the field of Phycotechnology. He has also earned multiple academic distinctions, including securing First Rank in his M.Sc. and receiving various endowment prizes from the University of Madras and his college. These honors reflect his commitment to academic excellence and his growing reputation in the field of plant biotechnology and Phycotechnology.

Conclusion:

Dr. Rajesh Kanna G. is highly deserving of recognition as a Best Researcher due to his exceptional research in Phycotechnology, his contributions to sustainable biotechnology, and his successful track record of academic excellence and innovation. His research not only addresses pressing environmental issues but also presents solutions with broad potential for industrial applications. While there is room to expand his collaborative efforts and visibility, his consistent research output, leadership in establishing a research center, and recognition through awards make him an outstanding candidate for this award.

Publication Top Notes:

  1. Biodegradation of polyethylene by green photosynthetic microalgae
    Authors: RV Kumar, GR Kanna, S Elumalai
    Journal: J Bioremediat Biodegrad 8 (381), 2
    Year: 2017
    Citation: 177
  2. Biodegradation of low-density polyethylene (LDPE) sheet by microalga, Uronema africanum Borge
    Authors: E Sanniyasi, RK Gopal, DK Gunasekar, PP Raj
    Journal: Scientific Reports 11 (1), 17233
    Year: 2021
    Citation: 76
  3. In vitro anti-HIV-1 activity of the bioactive compound extracted and purified from two different marine macroalgae (seaweeds) (Dictyota bartayesiana JV Lamouroux and Turbinaria…)
    Authors: E Sanniyasi, G Venkatasubramanian, MM Anbalagan, PP Raj, RK Gopal
    Journal: Scientific Reports 9 (1), 12185
    Year: 2019
    Citation: 55
  4. Retrospective and prospective application of robots and artificial intelligence in global pandemic and epidemic diseases
    Authors: A Yoganandhan, GR Kanna, SD Subhash, JH Jothi
    Journal: Vacunas (English Edition) 22 (2), 98-105
    Year: 2021
    Citation: 25
  5. Industrial production of Superoxide Dismutase (SOD): A mini review
    Authors: RK Gopal, S Elumalai
    Journal: J. Probiotics Health 5 (5)
    Year: 2017
    Citation: 18
  6. In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds
    Authors: E Sanniyasi, RK Gopal, R Damodharan, A Arumugam, M Sampath Kumar, …
    Journal: Scientific Reports 13 (1), 14452
    Year: 2023
    Citation: 16
  7. Extraction of carotenoid and thin layer chromatography (TLC), GC-MS, FT-IR and HPLC analysis of pharmaceutically important pigment astaxanthin from a new strain of…
    Authors: S Elumalai, BI Santhose, GR Kanna
    Journal: Weekly Science Research Journal 2 (8), 2321-7871
    Year: 2014
    Citation: 16
  8. Characterization and in vitro anticancer potential of exopolysaccharide extracted from a freshwater diatom Nitzschia palea (Kütz.) W.Sm. 1856
    Authors: RKGRD Elumalai Sanniyasi, Antony Prakash Rejoy Patrick, Kreedika Rajagopalan
    Journal: Scientific Reports 12, 22114
    Year: 2022
    Citation: 11
  9. Synthesis of bioethanol by dark fermentation using marine seaweed Acanthophora spicifera (Vahl.) Borgesen as a cheap substrate
    Authors: A Umamaheswari, P Saranraj, G Rajesh Kanna, S Elumalai, T Sangeetha
    Journal: Bioenergetics 6 (146), 2
    Year: 2017
    Citation: 7
  10. Extraction of phycocyanin an important pharmaceutical phycobiliproteins from cyanobacteria
    Authors: S Elumalai, KG Rajesh, G Jegan, T Sangeetha, SD Roop
    Journal: Int J Pharmaceut Res Dev 6, 67-74
    Year: 2014
    Citation: 7

 

Rahul Chaudhary | Medicine and Dentistry | Best Researcher Award

Dr. Rahul Chaudhary | Medicine and Dentistry | Best Researcher Award

Consultant Anesthesiologist at Birat medical college and teaching hospital, Nepal

Dr. Rahul Chaudhary is a highly accomplished anesthesiologist with over a decade of experience in managing complex cases across various medical specialties, including general surgery, orthopedics, gynecology, ophthalmology, urology, and more. He has gained specialized expertise in critical care management, particularly in trauma ICU, COVID-ICU, and pediatric anesthesia. His leadership extends to several subspecialties, such as neuroanesthesia, cardiac surgeries, robotic surgeries, and transplant surgeries. Dr. Chaudhary is known for his meticulous approach to anesthesia management, particularly for complex surgeries, including liver and renal transplants. He is also recognized for his ability to handle high-pressure situations, especially in the ICU setting, where he has managed critical and trauma patients effectively. As a researcher, educator, and clinician, Dr. Chaudhary has consistently demonstrated his commitment to improving patient outcomes and advancing the field of anesthesiology.

Professional Profile

Education

Dr. Rahul Chaudhary completed his MBBS from a reputed medical college in Nepal. He then pursued his postgraduate studies in Anaesthesia and Intensive Care at PGIMER, Chandigarh, where he earned his MD in Anesthesia. His educational journey reflects his deep commitment to medical excellence, where he focused on anesthesia management, critical care, and trauma care. Throughout his academic career, Dr. Chaudhary has been involved in several specialized training programs and certifications, including ACLS, ILS, and advanced anesthesia techniques like transesophageal echocardiography. His education has provided him with a comprehensive foundation in anesthesiology, preparing him to tackle some of the most challenging medical procedures and clinical situations.

Professional Experience

Dr. Rahul Chaudhary’s professional experience spans over several years, with significant contributions to both clinical and academic fields. He served as a Medical Officer and Chief Medical Officer at various institutions, including Rani PHC, before moving on to roles as a Consultant Anaesthesiologist. His most recent role is as an Anaesthesiologist at Birat Medical College and Teaching Hospital, Nepal. In this role, he manages anesthesia for a wide range of surgeries, including high-risk cardiac, neuro, and transplant surgeries. In addition to his clinical duties, Dr. Chaudhary has served as a faculty member in numerous Continuing Medical Education (CME) programs, sharing his knowledge and expertise in anesthesia management with medical professionals and trainees. His experience extends to critical care units, trauma management, and COVID-ICU, where his skills have been crucial in saving lives during the pandemic.

Research Interests

Dr. Rahul Chaudhary’s primary research interests are focused on the fields of anesthesiology, critical care, and trauma management. He has particularly concentrated on improving anesthesia techniques for complex surgeries, including maxillofacial trauma, pediatric surgeries, and cesarean sections. His research includes examining the best practices for neonatal anesthesia and the effects of anesthesia on postoperative outcomes. Another significant aspect of his research is the development of better airway management protocols and resuscitation methods, especially in emergency settings. Additionally, Dr. Chaudhary is dedicated to advancing the use of regional anesthesia in trauma and obstetric cases, with a focus on improving patient recovery and reducing complications. His interdisciplinary approach to research reflects his desire to improve patient outcomes across a variety of medical and surgical disciplines.

Research Skills

Dr. Chaudhary is skilled in conducting research on anesthesia management and critical care. His expertise includes designing and analyzing clinical studies, particularly in trauma and anesthesia management, and using statistical tools to evaluate outcomes. He is well-versed in various research methodologies, including case studies, clinical trials, and meta-analyses, particularly within the field of anesthesiology. His ability to conduct research under challenging conditions, such as in ICU settings and high-risk surgeries, makes him an expert in patient safety and anesthesia outcomes. Dr. Chaudhary has published numerous articles in peer-reviewed journals, and his ongoing research continues to influence best practices in anesthesia, trauma care, and critical care management.

Awards and Honors

Dr. Rahul Chaudhary has received several awards and recognitions throughout his career, underscoring his contributions to the field of anesthesiology and critical care. He has been acknowledged for his pioneering work in anesthesia management for high-risk surgeries, particularly in trauma and transplant cases. His research articles, many of which he has authored as the first author, have been published in respected medical journals, further enhancing his academic reputation. Dr. Chaudhary has also been a prominent speaker and faculty member at national and international conferences, sharing his knowledge on topics such as regional anesthesia and resuscitation techniques. His continued success in both clinical and academic arenas is a testament to his dedication to advancing medical knowledge and improving patient care in the field of anesthesiology.

Conclusion

Dr. Rahul Chaudhary is a highly skilled and knowledgeable anesthesiologist with a strong commitment to clinical care, teaching, and research. His leadership in anesthesiology, particularly in trauma, critical care, and innovative anesthesia techniques, positions him as a strong candidate for the Best Researcher Award. With continued expansion in research and global collaborations, Dr. Chaudhary is poised to make further significant contributions to his field.

Publication Top Notes

  1. Publication Title: A deep dive into neonatal well-being and anesthesia in cesarean sections: From procedure to outcome
    Authors: Chaudhary, R.K., Khan, S.A., Khanal, K., Rajbanshi, L.K., Jha, C.B.
    Journal: Medicine (United States)
    Year: 2024
    Volume: 103, Issue: 44, Article Number: e40404
  2. Publication Title: Molecular biology of carcinoid heart disease: Seeking therapeutic targets in the era of targeted therapy
    Authors: Khan, S.A., Devkota, D., Chaudhary, R.K., Bista, M., Rayamajhi, A.
    Journal: Medicine (United States)
    Year: 2023
    Volume: 102, Issue: 47, Article Number: E36043

 

Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Prof. Rumi Ueha | Medicine and Dentistry | Best Researcher Award

Director at Swallowing Center/The University of Tokyo Hospital, Japan

Dr. Rumi Ueha is a distinguished specialist in otolaryngology, focusing on airway surgery, swallowing disorders, and olfactory disorders. Holding both an M.D. and Ph.D., Dr. Ueha has accumulated significant expertise through her academic and clinical career. She has contributed extensively to the medical field, particularly in research concerning dysphagia, pediatric airway, chronic airway inflammation, and the regeneration of olfactory receptor cells. Dr. Ueha’s leadership is evident through her current position as Director and Associate Professor at the University of Tokyo, where she combines research, clinical practice, and mentorship. She is internationally recognized for her research in swallowing surgery and airway management, frequently collaborating with institutions across Japan and globally.

Professional Profile

Education:

Dr. Ueha earned her M.D. from the University of Tokyo in 2003, followed by her Ph.D. in 2017, also from the University of Tokyo. Her educational journey includes extensive training in otolaryngology and head and neck surgery, with specialized fellowships in broncho-esophagology. She has studied at renowned institutions, such as the University of California, Davis, and the University of Michigan, further solidifying her academic foundation. This rigorous education laid the groundwork for her research into complex disorders involving the airway, swallowing, and olfaction.

Professional Experience:

Dr. Ueha’s professional journey spans various prestigious roles, beginning as a resident and fellow in otolaryngology at the University of Tokyo and NTT Medical Center. Over the years, she advanced through key positions such as Assistant Professor and Project Lecturer, before being appointed as Director and Associate Professor. Her clinical and research work at the Swallowing Center of the University of Tokyo Hospital has contributed to groundbreaking advancements in dysphagia and swallowing surgery. She has also held visiting researcher roles, expanding her global network and research opportunities.

Research Interests:

Dr. Ueha’s research primarily focuses on the medical and surgical management of swallowing disorders (dysphagia), airway surgery, and olfactory disorders. She is particularly interested in swallowing surgery, chronic airway inflammation, and esophageal dysmotility. Dr. Ueha has explored innovative approaches in airway virtual reality, voice surgery, and pediatric airway management. Additionally, her work in olfactory receptor cell regeneration and the effects of aging on the olfactory system highlights her commitment to advancing treatment options for patients with sensory impairments. Her research also investigates the impact of SARS-CoV-2 on these systems.

Research Skills:

Dr. Ueha’s research skills are broad and multidisciplinary, combining clinical expertise with innovative technologies. She has demonstrated advanced knowledge in airway surgery, swallowing rehabilitation, and neurophysiology. Her skills also extend to virtual reality applications for airway management, showing her adaptability to emerging technologies. Dr. Ueha excels in clinical trials, with a focus on neuromuscular diseases and their impact on swallowing. Her ability to conduct translational research that bridges laboratory findings with clinical applications has led to advancements in treating complex airway and swallowing conditions.

Awards and Honors:

Dr. Ueha has received numerous prestigious awards in recognition of her contributions to otolaryngology and research. These include the Woman Award 2024 by the Oto-Rhino-Laryngological Society of Japan and the Excellence Award at the 16th Scientific Meeting of the Japanese Society of Anti-Aging Medicine. She has also been honored with several first-place prizes, including those for her management improvement projects at the University of Tokyo Hospital. Her recognition in the academic community extends to multiple journal editorial board positions, including for Auris Nasus Larynx and the Japanese Journal of Rhinology, where she influences advancements in her field.

Conclusion:

Dr. Rumi Ueha is a highly accomplished researcher and academic leader in the field of otolaryngology, particularly in swallowing disorders and airway surgery. Her strong academic background, multiple accolades, and extensive international experience make her an outstanding candidate for the Best Researcher Award. While further efforts in research funding and interdisciplinary collaborations would elevate her work, her substantial contributions to her field position her as a leader in otolaryngology and swallowing research.

Publication Top Notes

  • English as a Foreign Language Instructors’ Questioning Behaviors and Strategy Uses for Reflective Learning Facilitation
    • Authors: Not specified
    • Year: Not specified
  • A Narrative Review of Basic and Clinical Studies for Vocal Fold Regeneration Therapies
    • Authors: Cathrine Miura, Rumi Ueha, Maria Angela Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1016/j.anl.2024.10.011
  • A Retrospective Study of Cricotracheostomy: Indications, Techniques, and Clinical Outcomes
    • Authors: Kana Nanjo, Rumi Ueha, Maria A. Dealino, Naoyuki Matsumoto, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1002/ohn.1053
  • Swallowing Virtual Reality as a Novel Diagnostic Tool for Severe Dysphagia After Deep Neck Infection: A Case Report
    • Authors: Takahiro Katsuno, Rumi Ueha, Kana Nanjyo, Kazuaki Matsuda, Cathrine Miura, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.21203/rs.3.rs-4725568/v1
  • Esophageal Dysmotility in Multiple System Atrophy: A Retrospective Cross-Sectional Study
    • Authors: Rumi Ueha, Misaki Koyama, Akiko Seto, Taku Sato, Takao Goto, Kenta Orimo, Jun Mitsui, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.3390/jcm13175026
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report
    • Authors: Carmel Cotaoco, Takao Goto, Misaki Koyama, Taku Sato, Kenji Kondo, Rumi Ueha
    • Year: 2024
    • DOI: 10.1007/s42399-024-01713-2
  • Swallowing Improvement Surgeries
    • Authors: Carmel Cotaoco, Rumi Ueha, Misaki Koyama, Taku Sato, Takao Goto, Kenji Kondo
    • Year: 2024
    • DOI: 10.1007/s00405-024-08452-z
  • Severe Dysphagia in a Patient with Wallenberg Syndrome and Killian Jamieson Diverticulum: A Case Report (Preprint)
  • Use of CT for Dysphagia Evaluation: Advantages and Disadvantages in the Study of Swallowing
  • Three-Dimensional Computed Tomography Features of Recurrent Laryngeal Nerve Paralysis Due to Aortic Aneurysm
    • Authors: Jumpei Sasakawa, Takao Goto, Taku Sato, Misaki Koyama, Rumi Ueha, Tatsuya Yamasoba
    • Year: 2024
    • DOI: 10.1007/s42399-024-01685-3

 

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Girma Gilano | Health Professions | Best Researcher Award

Mr. Girma Gilano | Health Professions | Best Researcher Award Teacher of UESPI, Brazil.

Assistant prof. and PhD candidate at Arba Minch University, Ethiopia

Mr. Girma Gilano Kaso is an experienced Senior Researcher at Arba Minch University with a focus on public health informatics. He is currently pursuing a PhD at Maastricht University, specializing in digital health solutions and data management. His professional experience includes leading significant projects like digitalizing chronic disease management and enhancing health data quality. Mr. Kaso has a strong background in research, demonstrated by his work on mHealth impacts and systematic reviews. He has received recognition for his achievements in improving health management systems and has been actively involved in various organizational roles, including quality coordination and research leadership. His multilingual skills and professional memberships further enhance his contributions to the field.

Professional Profiles:

Education

Mr. Girma Gilano Kaso is currently pursuing a PhD at Maastricht University, Netherlands, focusing on radiography under Professor Andre Dekker (April 2022 – Present). He holds a Master’s degree in Public Health Informatics from the University of Gondar, Ethiopia (September 2009 – June 2012), where he was guided by Attinkut Alamirrew. His undergraduate studies were completed at Jimma University, Ethiopia, where he earned a BSc in General Nursing (September 2003 – June 2007) under the supervision of Bosana Tebeje.

Professional Experience

Mr. Girma Gilano Kaso is a Senior Researcher at Arba Minch University, Ethiopia, focusing on public health informatics since April 2017. Previously, he served as a Senior Researcher at Arba Minch College of Health Sciences from November 2009 to March 2017. During this time, he led impactful projects such as “Digitalizing Chronic Disease at Arba Minch General Hospital” (2018-2022) and improved Health Management Information System (HMIS) data quality in Southern Ethiopia (2020-2022). He also held significant roles including Clinical Department Head (2009-2011), Research Coordinator (2015-2017), and Institutional Quality Coordinator at Arba Minch University (2019-2022).

Research Interest

Mr. Girma Gilano Kaso specializes in public health informatics, focusing on digital health solutions and their impact on healthcare systems. His research includes evaluating the effectiveness of mHealth technologies on childhood vaccination and feeding practices in Africa. He is also interested in improving Health Management Information Systems (HMIS) to enhance data quality and information use. His work aims to integrate digital tools into healthcare settings to address chronic diseases and optimize health information systems.

 Award and Honors

Mr. Girma Gilano Kaso has achieved significant milestones in his career, notably leading a successful project on “Digitalizing Chronic Disease” at Arba Minch General Hospital, which was completed over four years (2018-2022). He has also contributed to the improvement of HMIS data quality in Southern Ethiopia. His notable reviews include systematic analyses of mHealth impacts on childhood vaccination and feeding practices in Africa. His work has earned him recognition in the field of public health informatics, showcasing his dedication to enhancing healthcare through innovative digital solutions.

Research Skills

Mr. Girma Gilano Kaso possesses extensive research skills in public health informatics, particularly in digital health and data management. His expertise includes leading and implementing projects focused on digitalizing chronic disease management and improving health management information systems. He has conducted systematic reviews and meta-analyses on mHealth impacts on vaccination and feeding practices in Africa. Proficient in utilizing various research methodologies, he combines strong analytical abilities with hands-on experience in health data quality improvement and digital health solutions. His contributions reflect a solid understanding of both theoretical and practical aspects of public health informatics.

Publications

  1. “Effect of mobile phone messaging on uptake of maternal and child health service in southern Ethiopia: Protocol for cluster randomized controlled trial”
    • Authors: Gilano, G., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: Clinical Nutrition Open Science
    • Volume: 54
    • Pages: 89–99
  2. “The effect of mHealth on childhood vaccination in Africa: A systematic review and meta-analysis”
    • Authors: Gilano, G., Sako, S., Molla, B., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume: 19(2)
    • Article ID: e0294442
  3. “The role of mHealth intervention to improve maternal and child health: A provider-based qualitative study in Southern Ethiopia”
    • Authors: Gilano, G., Dekker, A., Fijten, R.
    • Year: 2024
    • Journal: PLoS ONE
    • Volume: 19(2)
    • Article ID: e0295539
  4. “Assessing the effect of mHealth on child feeding practice in African countries: systematic and meta-analysis”
    • Authors: Gilano, G., Sako, S., Dileba, T., Dekker, A., Fijten, R.
    • Year: 2023
    • Journal: Journal of Health, Population and Nutrition
    • Volume: 42(1)
    • Page: 138
  5. “Individual and community-level factors associated with introducing prelacteal feeding in Ethiopia”
    • Authors: Gilano, G., Hailegebreal, S., Kashala, K., Gilano, K.
    • Year: 2023
    • Journal: Clinical Nutrition Open Science
    • Volume: 52
    • Pages: 14–24
  6. “Satisfaction of health informatics professionals with Ethiopian health system: the case of three zones in Ethiopia”
    • Authors: Gilano, G., Sako, S., Boranto, B., Haile, F., Hassen, H.
    • Year: 2023
    • Journal: BMC Health Services Research
    • Volume: 23(1)
    • Article ID: 615
  7. “Determinants of childhood vaccination among children aged 12-23 months in Ethiopia: a community-based cross-sectional study”
    • Authors: Sako, S., Gilano, G., Hailegebreal, S.
    • Year: 2023
    • Journal: BMJ Open
    • Volume: 13(3)
    • Article ID: e069278
  8. “Modern contraceptive use and associated factors among reproductive-age women in Ethiopia: multilevel analysis evidence from 2019 Ethiopia mini demographic and health survey”
    • Authors: Hailegebreal, S., Dileba Kale, T., Gilano, G., Haile, Y., Endale Simegn, A.
    • Year: 2023
    • Journal: Journal of Maternal-Fetal and Neonatal Medicine
    • Volume: 36(2)
    • Article ID: 2234067
  9. “Understanding the association of mass media with the timing of antenatal care in Ethiopia: an impression from the 2016 Ethiopia demographic and health survey”
    • Authors: Gilano, G., Hailegebreal, S., Sako, S., Seboka, B.T.
    • Year: 2023
    • Journal: Journal of Maternal-Fetal and Neonatal Medicine
    • Volume: 36(1)
    • Article ID: 2183760
  10. “Understanding Child Wasting in Ethiopia: Cross-sectional Analysis of 2019 Ethiopian Demographic and Health Survey Data Using Generalized Linear Latent and Mixed Models”
    • Authors: Gilano, G., Hailegebreal, S., Sako, S., Seboka, B.T., Kashala, K.
    • Year: 2023
    • Journal: JMIR Public Health and Surveillance
    • Volume: 9
    • Article ID: e39744